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Abstract Although previous chemical modi¢cation studies have
suggested several residues to be involved in the maintenance of
the quaternary structure of glutamate dehydrogenase (GDH),
there are con£icting views for the polymerization process and
no clear evidence has been reported yet. In the present study,
cassette mutagenesis at seven putative positions (Lys333,
Lys337, Lys344, Lys346, Ser445, Gly446, and His454) was
performed using a synthetic human GDH gene to examine the
polymerization process. Of the mutations at the seven di¡erent
sites, only the mutagenesis at His454 results in depolymeriza-
tion of the hexameric GDH into active trimers as determined by
HPLC gel ¢ltration analysis and native gradient polyacrylamide
gel electrophoresis. The mutagenesis at His454 has no e¡ects on
expression or stability of the protein. The KM values for NADH
and 2-oxoglutarate were 1.5-fold and 2.5-fold greater, respec-
tively, for the mutant GDH than for wild-type GDH, indicating
that substitution at position 454 had appreciable e¡ects on the
a⁄nity of the enzyme for both NADH and 2-oxoglutarate. The
Vmax values were similar for wild-type and mutant GDH. The
kcat/KM value of the mutant GDH was reduced up to 2.8-fold.
The decreased e⁄ciency of the mutant, therefore, results from
the increase in KM values for NADH and 2-oxoglutarate. The
results with cassette mutagenesis and HPLC gel ¢ltration anal-
ysis suggest that His454 is involved in the polymerization pro-
cess of human GDH.
8 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Glutamate dehydrogenase (GDH; EC 1.4.1.3) catalyzes the
reversible deamination of L-glutamate to 2-oxoglutarate using
NADþ or NADPþ as coenzyme [1]. GDH falls into two olig-
omeric classes. The bacterial and fungal NADPþ-linked and
vertebrate dual speci¢city GDHs have six identical subunits,
with a subunit size between 48 kDa (bacterial, e.g. Escherichia
coli) [2] and 55^57 kDa (vertebrate) [1,3], whereas the NADþ-
linked enzymes have either six identical subunits of around 48
kDa (e.g. Clostridium symbiosum) [4], or four identical sub-
units of 115 kDa (e.g. Neurospora crassa) [5].
The largest di¡erence between mammalian and bacterial
GDH is a long antenna domain formed by the 48 amino
acid insertion starting at residue 395 and there is little identity
between the 100 residues in the C-terminus [6]. In contrast to
the extensive allosteric regulations such as activation by ADP
and inhibition by GTP observed in mammalian GDH, bacte-
rial forms of GDH are relatively unregulated [1,7^9]. The
recently elucidated atomic structure of bovine liver GDH
has suggested that the allosteric regulation and negative co-
operativity observed in mammalian GDH may be facilitated
by subunit interactions via intra-trimer contacts and per-
formed by changing the energy required to open and close
the catalytic cleft during enzymatic turnover [10^12]. Re-
cently, it has been reported that mutations, such as S445L,
G446D, and H454Y, identi¢ed in patients with hyperinsulin-
ism^hyperammonemia syndrome are within exons 11 and 12
of GDH [13,14] and lie within a sequence of amino acids that
has been identi¢ed as a GTP binding site that is very close to
the antenna region [11,12,15,16]. Therefore, it seems likely
that the antenna may play a major role in subunit communi-
cation and that subunit communication responsible for neg-
ative cooperativity occurs. However, previous knowledge
from chemical modi¢cation studies has suggested that several
well conserved Lys residues including K333, K337, K344, and
K346 that are not close to the antenna region may play a role
in the regulation or maintenance of the quaternary structure
of GDH [17^26]. No direct experimental evidence has been
reported to identify the speci¢c amino acid residue(s) involved
in polymerization of hexameric human GDH. It is clear that
direct evidence such as site-directed mutagenesis would be
necessary to identify the residue(s) required for the polymer-
ization process of human GDH.
In the present work, we have expanded the identi¢cation of
the amino acid residue(s) involved in the polymerization pro-
cess of human GDH using cassette mutagenesis and high per-
formance liquid chromatography (HPLC) gel ¢ltration analy-
sis. For the present study, mutant human GDHs at seven
putative sites for polymerization of human GDH have been
expressed in E. coli as soluble proteins, puri¢ed, and charac-
terized. To our knowledge, this is the ¢rst study by site-di-
rected mutagenesis showing that His454 plays an important
role in the maintenance of the quaternary structure of human
GDH.
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2. Materials and methods
2.1. Materials
ADP, NADH, 2-oxoglutarate, and isopropyl-L-D-thiogalactose
(IPTG) were purchased from Sigma. Human GDH gene (pHGDH)
has been chemically synthesized and expressed in E. coli as a soluble
protein in our laboratory as described elsewhere [27]. ADP-Sepharose
and Resource-Q were purchased from Amersham Pharmacia Biotech.
Protein Pak DEAE-5PW column was purchased from Waters. Re-
striction enzymes were purchased from New England Biolabs. All
other chemicals and solvents were reagent grade or better.
2.2. Bacterial strains
E. coli DH5K [28] was used as the host strain for cassette muta-
genesis. E. coli PA340 (thr-1 fhuA2 leuB6 lacY1 supE44 gal-6 gdh-1
hisG1 rfbD1 galP63 v(gltB-F)500 rpsL19 malT1 xyl-7 mtl-2 argH1
thi-1 ; kindly provided by Dr. Mary K.B. Berlyn, E. coli Genetic Stock
Center, Yale University) lacked both GDH and glutamate synthase
activities [20] and was used to test plasmids for GDH activity. E. coli
BL21(DE3) [29] was used for high level expression of the recombinant
GDH.
2.3. Construction of mutants
A series of single amino acid substitutions was constructed by cas-
sette mutagenesis of plasmid pHGDH. Plasmid DNA (5 Wg) was
digested with restriction enzymes to remove the £anking fragment
that encodes target amino acids and the £anking fragment was re-
placed with seven synthetic DNA duplexes containing a substitution
on both DNA strands at di¡erent positions to make K333L, K337L,
K344L, K346L, S445L, G446D, and H454Y mutant proteins. Muta-
genic oligonucleotides were annealed, ligated, and transformed into
DH5K and the resultant mutant plasmids were identi¢ed by DNA
sequencing using plasmid DNA as a template. Each of these mutants
has been expressed in E. coli strain DE3 and puri¢ed to homogeneity,
and has had its steady-state kinetic parameters determined as de-
scribed below. The gene expression levels of the mutant proteins
were examined by Western blot using monoclonal antibodies previ-
ously produced in our laboratory against bovine brain GDH [30].
2.4. Protein puri¢cation and kinetic studies
Fresh overnight cultures of DE3/pHGDH were used to inoculate 1 l
of LB containing 100 Wg/ml ampicillin. DE3/pHGDH was grown at
37‡C until the A600 reached 1.0 and then IPTG was added to a ¢nal
concentration of 1 mM. After IPTG induction, DE3/pHGDH was
grown for an additional 3 h at 37‡C and then harvested by centrifu-
gation. Cell pellets were suspended in 100 ml of 100 mM Tris^HCl,
pH 7.4/1 mM EDTA/5 mM dithiothreitol and lysed with a sonicator.
Cellular debris was removed by centrifugation and the crude extracts
were loaded onto an ADP-Sepharose column (1.5U5 cm) that was
equilibrated with bu¡er A (50 mM Tris^HCl, pH 8.0, 1 mM EDTA,
and 5 mM dithiothreitol). The column was washed with bu¡er A until
the breakthrough peak of protein had been eluted. The enzyme was
then eluted by a gradient up to 500 mM NaCl in bu¡er A. The
fractions containing GDH activity were pooled, concentrated, and
applied to a FPLC Resource-Q anion exchange column equilibrated
with bu¡er A. The enzyme was then eluted using a linear gradient
made with bu¡er A in increasing concentrations of NaCl up to 100
mM at 0.5 ml/min. The puri¢ed GDH was analyzed by sodium do-
decyl sulfate^polyacrylamide gel electrophoresis. Protein concentra-
tion was determined by the method of Bradford [31] using bovine
serum albumin as a standard.
GDH activity was measured spectrophotometrically in the direction
of reductive amination of 2-oxoglutarate by following the decrease in
absorbance at 340 nm as described before [3]. One unit of enzyme
activity was de¢ned as the amount of enzyme required to oxidize
1 Wmol of NADH per minute at 25‡C. Since E. coli only has an
NADPH-dependent GDH [20], the enzyme assay was performed
with NADH as a coenzyme. For determination of KM and Vmax
values, the assays were carried out by varying the substrate under
investigation while keeping the other substrate and reagents at the
optimal concentrations. The KM and Vmax values were calculated by
linear regression analysis of double-reciprocal plots and are given
together with standard errors. Catalytic e⁄ciency was estimated by
use of the equation v/[E0] = (kcat/KM)[S] [32].
2.5. HPLC gel ¢ltration analysis
Molecular size of the wild-type and mutant proteins was determined
by a HPLC Protein-Pak 300SW gel ¢ltration column with a Waters
HPLC system. The column equilibrated with 100 mM Tris^HCl, pH
7.5 containing 0.05 M NaCl. The wild-type and mutant GDHs were
separately loaded onto a Protein-Pak 300SW column (Waters) and
eluted with the same bu¡er at a £ow rate of 1 ml/min. The protein
was monitored at 280 nm and the GDH activity was monitored by the
standard assay method as described above. The molecular size of the
wild-type and mutant GDHs was analyzed from the standard curve
performed with high molecular weight standard markers (Amersham
Pharmacia Biotech) under the same experimental conditions.
3. Results and discussion
To test the involvement of several putative amino acids in
subunit polymerization of human GDH, we constructed a
series of mutants at seven di¡erent sites by cassette mutagen-
esis. The £anking fragment in pHGDH was replaced with
synthetic DNA duplexes containing a substitution on both
DNA strands at positions encoding Lys333, Lys337, Lys344,
Lys346, Ser445, Gly446, and His454 to make K333L, K337L,
K344L, K346L, S445L, G446D, and H454Y mutant proteins.
The mutant proteins were e⁄ciently expressed in E. coli as
soluble proteins and homogeneously puri¢ed using ADP-Se-
pharose column followed by FPLC Resource-Q column.
Analysis of crude cell extracts by Western blot showed that
each mutant plasmid encoding an amino acid substitution at
seven di¡erent positions directed the synthesis of a 56.5 kDa
protein that interacted with monoclonal antibodies raised
against GDH at almost identical levels for all seven mutants
and wild-type GDH (Fig. 1). Speci¢c activities of these mu-
tants were 1.02^1.18 U/mg, compared with a wild-type value
of 1.12 U/mg, suggesting that the sites tested are not strictly
required for catalytic activity. These results indicate that mu-
tagenesis at the seven di¡erent sites has no e¡ects on expres-
sion or stability of the mutant enzymes. The mutant enzymes
also appeared to be as stable as wild-type human GDH, on
the basis of their stability toward proteolysis and retention of
activity upon prolonged storage at 4‡C (data not shown).
Table 1
Kinetic parameters of the puri¢ed wild-type GDH and mutant GDHs
kcat (s31) KM (mM) kcat=KM (s31 mM31)
NADH 2-Oxoglutarate NADH 2-Oxoglutarate
Wild-type 104 0.081 1.25 1284 83
K333L 93 0.079 1.29 1177 72
K337L 98 0.088 1.45 1113 68
K344L 105 0.090 1.31 1166 80
K346L 100 0.076 1.31 1315 76
S445L 111 0.098 1.47 1132 76
G446D 102 0.089 1.50 1146 68
H454Y 95 0.122 3.13 778 30
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A more detailed investigation of the catalytic activities of
the mutant enzymes revealed essentially unchanged apparent
KM values for 2-oxoglutarate and NADH as well as the re-
spective apparent Vmax values in K333L, K337L, K344L,
K346L, S445L, and G446D mutants (Table 1). The similarity
of the KM values for the wild-type and mutant enzymes in-
dicates that mutagenesis at the six positions does not a¡ect
the a⁄nity of the enzyme for these two substrates. However,
the H454Y mutant GDH showed a di¡erent kinetic pattern
from wild-type GDH. The KM values for 2-oxoglutarate were
1.25 and 3.13 mM, respectively, for the wild-type and H454Y
mutant GDH, and the KM values for NADH were 0.081 and
0.122 mM, respectively, for the wild-type and H454Y mutant
GDH (Table 1). The 2.5-fold and 1.5-fold greater KM values
for 2-oxoglutarate and NADH, respectively, for the K454Y
mutant GDH than for wild-type GDH suggest that substitu-
tion at position 454 had appreciable e¡ects on the a⁄nity of
the enzyme for both NADH and 2-oxoglutarate. The Vmax
values were similar for wild-type and H454Y mutant GDH,
but the enzyme e⁄ciency (kcat/KM) of the H454Y mutant
GDH was reduced up to 2.8-fold. The decreased enzyme e⁄-
ciency of the H454Y mutant, therefore, results from the in-
crease in KM values for NADH and 2-oxoglutarate.
The role of the seven residues in polymerization of human
GDH was further investigated by using HPLC gel ¢ltration
analysis. Calibration was performed with the high molecular
marker proteins: thyroglobulin (670 kDa), ferritin (440 kDa),
catalase (230 kDa), and aldolase (160 kDa). The retention
times of the marker proteins were 5.1, 6.4, 7.3, and 7.7 min,
respectively (Fig. 2 and Table 2). The result of gel ¢ltration on
HPLC Protein Pak 300SW column shows the identical reten-
tion time with the calculated molecular size of approximately
330 kDa for both wild-type GDH and mutant GDHs at posi-
tions Lys333, Lys337, Lys344, Lys346, Ser445, and Gly446
(Table 2). Since GDH is composed of identical subunits
with a molecular size of V56 kDa, these results indicate
that the wild-type GDH and these mutant GDHs are com-
posed of six identical subunits. The present work shows that
kinetic parameters and molecular size of the mutant GDHs at
positions Lys333, Lys337, Lys344, Lys346, Ser445, and
Gly446 are almost identical with those of wild-type (Table
1, Fig. 2), suggesting that subunit composition and polymer-
ization process of the mutant GDHs are not a¡ected by the
mutagenesis at each target amino acid. Although previous
studies have suggested a possibility for the involvement of
the residues at positions Lys333, Lys337, Lys344, Lys346,
Ser445, and Gly446 in the maintenance of quaternary struc-
ture or subunit communication of mammalian GDH [11^
14,17^23], the results from the present work show that those
residues do not have a direct role for the polymerization pro-
cess of hexameric human GDH.
Unlike the mutant GDHs at positions Lys333, Lys337,
Lys344, Lys346, Ser445, and Gly446, there were di¡erences
in the biochemical properties between wild-type and His454
mutant GDH. The H454L mutant GDH shows a retention
time of 7.7 min with a calculated molecular size of 160 kDa
suggesting a composition of three subunits instead of a hex-
americ form (Fig. 2 and Table 2). Of the mutations at the
seven di¡erent sites tested, therefore, only the mutagenesis at
position His454 speci¢cally results in depolymerization of the
hexameric GDH into trimers. The KM values for NADH and
2-oxoglutarate increased 1.5-fold and 2.5-fold, respectively, in
1 2 3 4 5 6 7 8 9
hGDH
Fig. 1. Western blot analysis of the mutant GDHs in crude extracts.
The supernatants of the crude extracts were loaded on a 12% so-
dium dodecyl sulfate^polyacrylamide gel, subjected to electrophore-
sis and immunoblotted with the monoclonal antibody directed
against bovine brain GDH [30]. The ¢nal amount of total proteins
loaded on each lane (lanes 2^9) was 0.8 mg. Lane 1, prestained
marker proteins (Novex); lane 2, wild-type GDH; lanes 3^9, mutant
GDHs (K333L, K337L, K344L, K346L, S445L, G446D, and
H454Y).
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Fig. 2. HPLC gel ¢ltration elution pro¢les. The puri¢ed wild-type
and mutant GDHs were loaded onto a Protein-Pak 300SW gel ¢l-
tration column equilibrated with 100 mM Tris^HCl, pH 7.5 con-
taining 0.05 M NaCl. Proteins were eluted by the same bu¡er at a
£ow rate of 1.0 ml/min, monitored for protein at 280 nm, and as-
sayed as described in the text. One-minute fractions were collected.
Calibration was performed with the gel ¢ltration high molecular
weight marker proteins (dashed lines) from Amersham Pharmacia
Biotech: thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232
kDa), and aldolase (158 kDa). The solid lines represent wild-type
(a) and H454Y mutant GDH (b). Elution pro¢les of K333L,
K337L, K344L, K346L, S445L, and G446D mutants were identical
with those of wild-type and are not shown for clarity.
Table 2
Molecular size of the wild-type and mutant GDHs
Retention time (min) Molecular size (kDa)
Wild-type 7.0 330
K333L 7.0 330
K337L 7.0 330
K344L 7.0 330
K346L 7.0 330
S445L 7.0 330
G446D 7.0 330
H454Y 7.7 160
Thyroglobulin 5.1 670
Ferritin 6.4 440
Catalase 7.3 230
Aldolase 7.7 160
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the His454 mutant compared to those of the wild-type GDH
(Table 1). Although the mutation at position 454 produces
changes in the apparent KM values for NADH and 2-oxoglu-
tarate, H454Y mutant GDH and wild-type GDH show sim-
ilar speci¢c activities and kcat values of the same order of
magnitude (Table 1). The results of Western blot analysis
(Fig. 1) show that the mutagenesis at His454 has no e¡ects
on expression or stability of the H454Y mutant GDH. There-
fore, the dramatic reduction in the catalytic e⁄ciency (kcat/
KM) of the H454Y mutant re£ects primarily changes in the
KM values for substrates, especially for 2-oxoglutarate.
Next we performed native gradient acrylamide gel electro-
phoresis to further con¢rm the native molecular size of the
mutant GDHs. The results in Fig. 3 show that the molecular
sizes of the mutant GDHs at positions Lys333, Lys337,
Lys344, Lys346, Ser445, and Gly446 are almost identical
with those of wild-type, whereas the H454L mutant GDH
shows a di¡erent migration with a calculated molecular size
of 170 kDa suggesting a composition of three subunits instead
of a hexameric form. These results are consistent with those
observed in HPLC gel ¢ltration analysis (Fig. 2), demonstrat-
ing that mutagenesis at the His454 site results in the depoly-
merization of hexameric human GDH into trimers.
The His454 site identi¢ed as a functional residue in the
polymerization of GDH in the present work is exactly located
within the GTP binding domain that is very close to the
antenna region. It has been reported that the six glutamate
binding domains form the core of the GDH hexamer [11,12].
Since the six glutamate binding domains form an apparently
rigid core structure as the catalytic cleft opens and closes, it
seems likely that the subunit communication responsible for
negative cooperativity occurs via intra-trimer contacts. Unlike
mammalian GDHs, bacterial GDH does not exhibit negative
cooperativity and does not have the antenna domain. It
should, therefore, be mentioned that the antenna might play
a major role in the subunit communication. Our results with
cassette mutagenesis and HPLC gel ¢ltration analysis suggest
the possibility that His454 plays an important role in the
polymerization process of hexameric human GDH, although
the detailed kinetics of the H454Y mutant, in particular by
rapid reaction kinetics and subunit complementation analysis,
remains to be studied in order to elucidate the role of this
residue more fully.
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Fig. 3. Native gradient polyacrylamide gel electrophoresis of wild-
type and mutant GDHs. The puri¢ed wild-type and mutant GDHs
were separated on 5^12.5% polyacrylamide native gradient gel at
4‡C and stained with Coomassie blue R-350. Lane 1, high molecular
weight native gel electrophoresis markers (Amersham Pharmacia
Biotech); lane 2, H454Y mutant; lanes 3^8, mutant GDHs (K333L,
K337L, K344L, K346L, S445L, and G446D); lane 9, wild-type.
Numbers beside arrows represent molecular weight in kDa.
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